ITM negatíve jelentés esetén a NEL lejtmenetben követni fogja az ITM Power-t.
Ebben az esetben a NEL ASA vételét csak a jelentést megelőző 3 kereskedési nappal ajánlo.
In case negative report NEL will follow ITM to the downside prior to 3D NEL ER report.
Ebben az esetben a NEL ASA vételét csak a jelentést megelőző 3 kereskedési nappal ajánlo.
In case negative report NEL will follow ITM to the downside prior to 3D NEL ER report.
Note
The last ER was not good enough for the higher NEL share price. Soon NEL can demonstrate that they keep their words, and if its will be reflected in the coming ER you can be sure to see old price as 31NOKNote
Invitation to presentation of Q1 2022 results(𝗡𝗲𝗹, 𝗢𝗦𝗘:𝗡𝗘𝗟) 𝘄𝗶𝗹𝗹 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝗶𝘁𝘀 𝗳𝗶𝗿𝘀𝘁 𝗾𝘂𝗮𝗿𝘁𝗲𝗿 𝟮𝟬𝟮𝟮 𝗿𝗲𝗽𝗼𝗿𝘁 𝗼𝗻 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆 𝟭𝟭 𝗠𝗮𝘆 𝗮𝘁 𝟬𝟳:𝟬𝟬 𝗖𝗘𝗧 𝗮𝗻𝗱 𝘄𝗶𝗹𝗹 𝗵𝗼𝘀𝘁 𝗮 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗮𝘁 𝟬𝟴:𝟬𝟬 𝗖𝗘𝗧.
𝙏𝙝𝙚 𝙥𝙧𝙚𝙨𝙚𝙣𝙩𝙖𝙩𝙞𝙤𝙣 𝙬𝙞𝙡𝙡 𝙗𝙚 𝙝𝙚𝙡𝙙 𝙖𝙩 𝙃𝙤𝙩𝙚𝙡 𝘾𝙤𝙣𝙩𝙞𝙣𝙚𝙣𝙩𝙖𝙡 ( Well his is interesting, why there, and at the headquarter in Oslo)
Source:
nelhydrogen.com/press-release/nel-asa-invitation-to-presentation-of-q1-2022-results/
The presentation will be broadcasted live at nelhydrogen.com and can also be streamed at channel.royalcast.com/landingpage/hegnarmedia/20220511_1/. Physical participation is welcomed.
The report and presentation will be made available through newsweb.no and nelhydrogen.com.
Please note there has been a change in the financial calendar for Q2 2022. The 𝙣𝙚𝙬 𝙙𝙖𝙩𝙚 𝙛𝙤𝙧 𝙩𝙝𝙚 𝙧𝙚𝙡𝙚𝙖𝙨𝙚 𝙤𝙛 𝙩𝙝𝙚 𝙧𝙚𝙨𝙪𝙡𝙩𝙨 𝙛𝙤𝙧 𝙌𝟮 𝙝𝙖𝙨 𝙗𝙚𝙚𝙣 𝙨𝙚𝙩 𝙩𝙤 𝟭𝟭. 𝘼𝙪𝙜𝙪𝙨𝙩 𝟮𝟬𝟮𝟮.
Estimates
Revenue 280M-NOK EPS - -0,01
Countdown
channel.royalcast.com/hegnarmedia/
Note
Dear Investors! It's time to buy this particular stock. Seasonality of energy stock is coming. What do you need to sell or take some profit?
All the vacation stocks: Like hotels, cruise ships beverages (alcohol)..
In my next post, I will elaborate the future of NEL ASA.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.